Table 1 Clinical characteristics and treatment methods of evaluable patients
From: Management of orbital invasion in esthesioneuroblastoma: 14 years’ experience
Variable | No. (%) |
|---|---|
Median age, yr. (range) | 54 (22–77) |
Sex | |
Male | 44 (73.3%) |
Female | 16 (26.7%) |
Degree of orbital invasiona | |
Grade I | 12 (20%) |
Grade II | 23 (38.3%) |
Grade III | 25 (41.7%) |
Foote stage | |
C | 52 (86.7%) |
D | 8 (13.3%) |
Lymph node classification | |
N0 | 52 (86.7%) |
N+ | 8 (13.3%) |
Orbital symptoms | |
Yes | 41 (68.3%) |
No | 19 (31.7%) |
Treatment methods | |
Radical radiation | 14 (23.3%) |
Preoperative radiation + surgery | 21 (35%) |
Postoperative radiation +surgery | 25 (41.7%) |
Surgical methods | |
Endoscopic group | 33 (71.7%) |
Open groupb | 13 (28.3%) |
Management of neck | |
PENI | 25 (41.6%) |
TENI | 7 (11.7%) |
END | 1 (1.7%) |
No management | 27 (45%) |
Type of radiotherapy | |
3D-CRT | 34 (56.7%) |
IMRT | 26 (43.3%) |
Chemotherapy | |
Yes | 47 (78.3%) |
No | 13 (21.7%) |